3D 打印药品全球市场规模研究,按技术,按应用,按最终用途,按地区预测 2022-2028
市场调查报告书
商品编码
1132004

3D 打印药品全球市场规模研究,按技术,按应用,按最终用途,按地区预测 2022-2028

Global 3D Printed Drugs Market Size study, by Technology, By Application, By End-use and Regional Forecasts 2022-2028

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球 3D 打印药品市场价值约为 7202 万美元,预计在 2022-2028 年的预测期内以超过 15.30% 的健康增长率增长。

3D 打印药物是通过 3D 打印过程创建的处方,旨在为个人提供安全、有效和量身定制的药物。这些药物不需要整个吞服,因为它们的一体式多孔结构很容易在口腔中分散。这使生产商可以轻鬆修改不同药物的大小、形状、外观和分布动力学。由于对个性化医疗的需求不断增长,以及支持 3D 打印的研发活动迅速扩大,市场正在蓬勃发展。这项技术通过实现个性化医疗为改善患者护理创造了有希望的机会。为了使药物更安全、更有效,自 2015 年美国个性化医学倡议成立以来,製药研究公司也一直在寻求开发更专业的治疗方法。因此,预计未来几年对 3D 打印药品的需求将会增长。增加运营商对生产先进有效的 3D 打印药品的投资以及 3D 打印技术的突破预计将在预测期内推动市场增长。例如,CurfiyLabs 和 Natural Machines 于 2022 年 3 月合作,根据患者的个体需求生产这些药物。希望这将使药店和医院能够更快地收到药品。然而,这些药物的副作用、使用 3D 打印机开发非法药物以及政府对 3D 打印机产品缺乏监管等都是阻碍市场扩张的因素。另一方面,随着新兴国家医疗保健系统和技术的突破,人们对这些药物的快速溶解等益处的普遍认识有望为市场扩张创造广阔的潜力。

全球 3D 打印药品市场研究考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。亚太地区在 3D 打印药物市场拥有最大的市场份额,预计在预测期内将以健康的复合年增长率增长。医疗基础设施的快速发展和医疗研发投资的增加预计将推动亚太地区 3D 打印药品市场的增长。由于欧洲人的健康意识不断增强,预计欧洲地区在预测期内也将实现令人满意的增长。

本报告中包含的主要市场参与者是:

  • Extend Biosciences
  • BioDuro
  • Affinity Therapeutics
  • Osmotica Pharmaceuticals
  • Aprecia Pharmaceuticals LLC
  • GlaxoSmithKline Plc
  • FabRx Ltd
  • Hewlett Packard Caribe
  • Merck

本研究的目的是确定近年来各个细分市场和国家/地区的市场规模,并预测未来 8 年的价值。该报告旨在包括按地区和国家研究的行业的定性和定量方面。此外,它还提供了有关关键方面的详细信息,例如定义市场未来增长的驱动因素和挑战。此外,报告还应详细分析主要参与者的竞争格局和产品供应,以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。

按技术

喷墨打印

熔融增材製造

立体光刻

ZipDose 技术

按应用程序

骨科

神经

牙科

杂项

按最终用户

医院/诊所

研究所

杂项

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地方

此外,本研究考虑的年份是:

实际年份 - 2018 年、2019 年、2020 年

2021 年基准年

预测期 - 2022 年 至 2028 年

本报告的目标受众是全球 3D 打印药品市场。

主要咨询公司和顾问

大公司、中型公司、中小企业

风险投资

增值经销商 (VAR)

第三方知识提供者

投资银行家

投资者

内容

第 1 章执行摘要

  • 市场快照
  • 2020-2028 年全球市场细分的估计和预测
    • 2020-2028 年按地区分列的 3D 打印药品市场
    • 3D 打印药品市场:按技术,2020-2028
    • 2020-2028 年按应用分列的 3D 打印药品市场
    • 3D 打印药品市场:按最终用途分类(2020-2028 年)
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章 3D 打印药剂的全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第 3 章全球 3D 打印药品市场动态

  • 3D 打印药品市场影响分析(2020-2028)
    • 市场驱动力
      • 3D 打印在医疗行业的使用率不断提高
      • 扩大个性化药物的采用
    • 市场挑战
      • 政府对 3D 打印产品缺乏监管
    • 市场机会
      • 对速溶片的高需求

第 4 章 3D 打印药品全球市场行业分析

  • 波特的 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
    • 到波特的 5 力模型 未来主义方法(2018-2028)
  • PEST 分析
    • 政治
    • 经济
    • 社交
    • 技术
  • 招商引资模式
  • 分析师的结论和建议
  • 热门投资机会
  • 关键成功策略

第 5 章风险评估:COVID-19 的影响

    • 评估 COVID-19 对行业的整体影响
    • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球 3D 打印药品市场:按技术分类

  • 市场快照
  • 按技术分列的 3D 打印药品全球市场 , 按性能, 潜力分析
  • 2018-2028 年全球 3D 打印药品市场、技术估计和预测
  • 3D 打印药品市场,按细分市场分析
    • 喷墨打印
    • 融合增材製造
    • 立体光刻
    • ZipDose 技术 诺学

第 7 章全球 3D 打印药品市场:按应用分类

  • 市场快照
  • 3D 打印药剂的全球市场:按应用分列的性能和潜力分析
  • 2018-2028 年全球 3D 打印药剂市场、估计和预测(按应用)
  • 3D 绘图 皮棉製药市场,细分分析
    • 骨科
    • 神经科
    • 牙科
    • 其他

第 8 章全球 3D 打印药品市场:按最终用途分类

  • 市场快照
  • 3D 打印药剂的全球市场:按最终用途划分的实际情况 性能/潜力分析
  • 2018-2028 年全球 3D 打印药品市场、估计和预测(按最终用途)
  • 3D 打印药品市场,细分分析
    • 医院和诊所
    • 研究所
    • 其他

第 9 章 3D 打印药物代理的全球市场:区域 区域分析

  • 3D 打印药物代理的全球市场,区域市场快照
  • 北美
    • 美国
      • 2018-2028 年按技术划分的估计和预测
      • 按应用划分的估计和预测,2018-2028
      • 按最终用途划分的估计和预测,2018 年 2028-2028
    • 加拿大
  • 欧洲 3D 打印药品市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太 3D 打印药品市场概览
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲 3D 打印药品市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第十章比赛 匹配信息

  • 顶级市场策略
  • 公司简介
    • 扩展生物科学
      • 主要信息
      • 概览
      • 财务(取决于数据可用性)
      • 应用概览
      • 近期发展
    • Bioduro
    • 亲和力 疗法
    • Osmotica Pharmaceuticals
    • Aprecia Pharmaceuticals LLC
    • GlaxoSmithKline Plc
    • FabRx Ltd
    • Hewlett Packard Caribe
    • Merck

第 11 章研究过程

  • 研究过程
    • 数据挖掘 G
    • 分析
    • 市场估算
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global 3D Printed Drugs Market is valued at approximately USD 72.02 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.30% over the forecast period 2022-2028. 3D printed drugs are prescriptions created with the 3D printing process to provide individuals with safe and effective tailored medications. These drugs don't need to be swallowed whole because of the unitary porous architecture that makes it simple for them to scatter in the mouth. It makes it simple for producers to alter the size, shape, appearance, and rate of distribution of a variety of medications. The market is booming as a result of rising demand for personalized drugs and rapidly expanding R&D activities supporting 3D printing. By producing personalized medical therapies, this technology creates promising opportunities for improving patient care. To make pharmaceuticals safer and more effective, pharmaceutical research companies have also been looking into the development of more specialised remedies since the establishment of the United States Personalized Medicine Initiative in 2015. As a result, demand for 3D-printed drugs is expected to increase in the coming years.Increased investments by operating players in the production of advanced and effective 3D printed pharmaceuticals, as well as breakthroughs in 3D printing technology, are expected to drive market growth over the forecast period. CurfiyLabs and Natural Machines, for example, collaborated in March 2022 on the production of these medicines based on the needs of individual patients. This is expected to allow pharmacies and hospitals to receive medications more quickly. However, the adverse effects of these drugs, the development of illicit drugs using 3D printing and the absence of government restrictions for 3D printed goods are two factors that are limiting market expansion. On the other hand, growing public knowledge of the advantages of these medications, such as their rapid solubility, along with breakthroughs in healthcare systems and technology in emerging nations, are anticipated to create a wide range of potential for market expansion.

The key regions considered for the global 3D Printed Drugs market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has the largest market share in the 3D printed drugs market and is expected to grow at a healthy CAGR during the forecast period. Rapid development of healthcare infrastructure and increased investment in healthcare research and development are expected to drive the growth of the Asia Pacific 3D printed drugs market. The Europe region is also expected to grow satisfactorily during the forecast period, owing to rising health consciousness among Europeans.

Major market players included in this report are:

Extend Biosciences

BioDuro

Affinity Therapeutics

Osmotica Pharmaceuticals

Aprecia Pharmaceuticals LLC

GlaxoSmithKline Plc

FabRx Ltd

Hewlett Packard Caribe

Merck

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByTechnology:

Inkjet Printing

Fused Deposition Modeling

Stereolithography

ZipDose Technology

By Application:

Orthopedic

Neurology

Dental

Others

By End-use:

Hospitals & clinics

Research Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global 3D Printed Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. 3D Printed Drugs Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. 3D Printed Drugs Market, by Technology,2020-2028 (USD Million)
    • 1.2.3. 3D Printed Drugs Market, by Application,2020-2028 (USD Million)
    • 1.2.4. 3D Printed Drugs Market, by End-use,2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global 3D Printed Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global 3D Printed Drugs Market Dynamics

  • 3.1. 3D Printed Drugs Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Usage Of 3D Printing in The Medical Industries
      • 3.1.1.2. Increasing Adoption of Personalized Drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack Of Government Regulations for 3D Printed Products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. High Demand for Instantaneous Soluble Tablets

Chapter 4. Global 3D Printed Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global 3D Printed Drugs Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global 3D Printed Drugs Market by Technology, Performance - Potential Analysis
  • 6.3. Global 3D Printed Drugs Market Estimates & Forecasts by Technology,2018-2028 (USD Million)
  • 6.4. 3D Printed Drugs Market, Sub Segment Analysis
    • 6.4.1. Inkjet Printing
    • 6.4.2. Fused Deposition Modeling
    • 6.4.3. Stereolithography
    • 6.4.4. ZipDose Technology

Chapter 7. Global 3D Printed Drugs Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global 3D Printed Drugs Market by Application, Performance - Potential Analysis
  • 7.3. Global 3D Printed Drugs Market Estimates & Forecasts by Application,2018-2028 (USD Million)
  • 7.4. 3D Printed Drugs Market, Sub Segment Analysis
    • 7.4.1. Orthopedic
    • 7.4.2. Neurology
    • 7.4.3. Dental
    • 7.4.4. Others

Chapter 8. Global 3D Printed Drugs Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global 3D Printed Drugs Market by End-use, Performance - Potential Analysis
  • 8.3. Global 3D Printed Drugs Market Estimates & Forecasts by End-use,2018-2028 (USD Million)
  • 8.4. 3D Printed Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospitals & clinics
    • 8.4.2. Research Laboratories
    • 8.4.3. Others

Chapter 9. Global 3D Printed Drugs Market, Regional Analysis

  • 9.1. Global 3D Printed Drugs Market, Regional Market Snapshot
  • 9.2. North America 3D Printed Drugs Market
    • 9.2.1. U.S. 3D Printed Drugs Market
      • 9.2.1.1. Technology breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada3D Printed Drugs Market
  • 9.3. Europe 3D Printed Drugs Market Snapshot
    • 9.3.1. U.K. 3D Printed Drugs Market
    • 9.3.2. Germany 3D Printed Drugs Market
    • 9.3.3. France 3D Printed Drugs Market
    • 9.3.4. Spain 3D Printed Drugs Market
    • 9.3.5. Italy 3D Printed Drugs Market
    • 9.3.6. Rest of Europe3D Printed Drugs Market
  • 9.4. Asia-Pacific 3D Printed Drugs Market Snapshot
    • 9.4.1. China 3D Printed Drugs Market
    • 9.4.2. India 3D Printed Drugs Market
    • 9.4.3. Japan 3D Printed Drugs Market
    • 9.4.4. Australia 3D Printed Drugs Market
    • 9.4.5. South Korea 3D Printed Drugs Market
    • 9.4.6. Rest of Asia Pacific 3D Printed Drugs Market
  • 9.5. Latin America 3D Printed Drugs Market Snapshot
    • 9.5.1. Brazil 3D Printed Drugs Market
    • 9.5.2. Mexico 3D Printed Drugs Market
  • 9.6. Rest of The World 3D Printed Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Extend Biosciences
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Application Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Bioduro
    • 10.2.3. Affinity Therapeutics
    • 10.2.4. Osmotica Pharmaceuticals
    • 10.2.5. Aprecia Pharmaceuticals LLC
    • 10.2.6. GlaxoSmithKline Plc
    • 10.2.7. FabRx Ltd
    • 10.2.8. Hewlett Packard Caribe
    • 10.2.9. Merck

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global 3D Printed Drugs Market, report scope
  • TABLE 2. Global 3D Printed Drugs Market estimates & forecasts by Region2018-2028 (USD Million)
  • TABLE 3. Global 3D Printed Drugs Market estimates & forecasts by Technology 2018-2028 (USD Million)
  • TABLE 4. Global 3D Printed Drugs Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 5. Global 3D Printed Drugs Market estimates & forecasts by End-use 2018-2028 (USD Million)
  • TABLE 6. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global 3D Printed Drugs Market
  • TABLE 56. List of primary sources, used in the study of global 3D Printed Drugs Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global 3D Printed Drugs Market, research methodology
  • FIG 2. Global 3D Printed Drugs Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global 3D Printed Drugs Market, key trends 2021
  • FIG 5. Global 3D Printed Drugs Market, growth prospects 2022-2028
  • FIG 6. Global 3D Printed Drugs Market, porters 5 force model
  • FIG 7. Global 3D Printed Drugs Market, pest analysis
  • FIG 8. Global 3D Printed Drugs Market, value chain analysis
  • FIG 9. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global 3D Printed Drugs Market, regional snapshot 2018 & 2028
  • FIG 15. North America 3D Printed Drugs Market2018 & 2028 (USD Million)
  • FIG 16. Europe 3D Printed Drugs Market2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific 3D Printed Drugs Market2018 & 2028 (USD Million)
  • FIG 18. Latin America 3D Printed Drugs Market2018 & 2028 (USD Million)
  • FIG 19. Global 3D Printed Drugs Market, company market share analysis (2021)